Sutekast 12.5 mg for fertility treatment Exporter from India to Washington, USA, Zimbabwe & New Zealand
City Drug Exporters specializes in exporting Sutekast 12.5 mg from India to international markets including Washington, USA, Zimbabwe, and New Zealand. We provide dependable supply solutions for pharmaceutical wholesalers, distributors, pharmacies, and healthcare procurement companies.
Sutekast 12.5 mg contains Sunitinib used in fertility treatment. Know its uses, benefits , Side effects, and storage details.
Sutekast 12.5 mg Capsule classified as a tyrosine kinase inhibitor, which means it works by blocking certain enzymes called tyrosine kinases involved in the growth and spread of cancer cells.
Side effects : Fatigue, nausea and vomiting, diarrhoea, loss of appetite, hand-foot syndrome, skin discoloration or rash, high blood pressure, headache, hair loss, changes in taste, dry skin or itching and nosebleeds.
Uses :
Renal cell carcinoma (RCC)
Gastrointestinal stromal tumors (GIST)
Pancreatic neuroendocrine tumors (PNET)
Medullary thyroid cancer
Certain kidney cancer
Safety Advice :
Breast Feeding :
It is unknown whether Sutekast 12.5mg Capsule is excreted in human breast milk. Breastfeeding women should discuss the potential risks and benefits of the medication with their healthcare provider before starting treatment.
Alcohol-
It is generally recommended to avoid consuming alcohol during treatment with Sutekast 12.5mg Capsule, as alcohol can potentially interfere with the effectiveness of the medication and increases liver-related and other potential side effects.
Liver-
Sutekast 12.5mg Capsule can cause liver toxicity, which can be severe or fatal in some cases. Patients taking this medication should be done their liver function tests regularly, and treatment should be interrupted or discontinued if these tests are abnormal.
Lungs-
Sutekast 12.5mg Capsule can cause interstitial lung disease (ILD), a serious and potentially fatal condition that causes scarring of the lungs. Patients taking this medication should be monitored for symptoms of ILD, such as cough, shortness of breath, and fever, and treatment should be interrupted or discontinued if necessary.
Driving-
Patients receiving Sutekast 12.5mg Capsule are advised to avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision, impairing a patient's ability to drive or operate machinery safely.
Pregnancy-
Sutekast 12.5mg Capsule is unsafe for a developing fetus and is not recommended during pregnancy as it can cause harm to the developing fetus.
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 7666132978
City Drug Exporters specializes in exporting Sutekast 12.5 mg from India to international markets including Washington, USA, Zimbabwe, and New Zealand. We provide dependable supply solutions for pharmaceutical wholesalers, distributors, pharmacies, and healthcare procurement companies.
Sutekast 12.5 mg contains Sunitinib used in fertility treatment. Know its uses, benefits , Side effects, and storage details.
Sutekast 12.5 mg Capsule classified as a tyrosine kinase inhibitor, which means it works by blocking certain enzymes called tyrosine kinases involved in the growth and spread of cancer cells.
Side effects : Fatigue, nausea and vomiting, diarrhoea, loss of appetite, hand-foot syndrome, skin discoloration or rash, high blood pressure, headache, hair loss, changes in taste, dry skin or itching and nosebleeds.
Uses :
Renal cell carcinoma (RCC)
Gastrointestinal stromal tumors (GIST)
Pancreatic neuroendocrine tumors (PNET)
Medullary thyroid cancer
Certain kidney cancer
Safety Advice :
Breast Feeding :
It is unknown whether Sutekast 12.5mg Capsule is excreted in human breast milk. Breastfeeding women should discuss the potential risks and benefits of the medication with their healthcare provider before starting treatment.
Alcohol-
It is generally recommended to avoid consuming alcohol during treatment with Sutekast 12.5mg Capsule, as alcohol can potentially interfere with the effectiveness of the medication and increases liver-related and other potential side effects.
Liver-
Sutekast 12.5mg Capsule can cause liver toxicity, which can be severe or fatal in some cases. Patients taking this medication should be done their liver function tests regularly, and treatment should be interrupted or discontinued if these tests are abnormal.
Lungs-
Sutekast 12.5mg Capsule can cause interstitial lung disease (ILD), a serious and potentially fatal condition that causes scarring of the lungs. Patients taking this medication should be monitored for symptoms of ILD, such as cough, shortness of breath, and fever, and treatment should be interrupted or discontinued if necessary.
Driving-
Patients receiving Sutekast 12.5mg Capsule are advised to avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision, impairing a patient's ability to drive or operate machinery safely.
Pregnancy-
Sutekast 12.5mg Capsule is unsafe for a developing fetus and is not recommended during pregnancy as it can cause harm to the developing fetus.
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 7666132978
Keywords
